AST-120 Used to Treat Mild Hepatic Encephalopathy

Status:
Completed

Trial end date:
2010-06-01

Target enrollment:

Participant gender:

The purpose of this study is to determine whether AST-120 is safe and effective in the treatment of mild hepatic encephalopathy.

Phase 2

Ocera Therapeutics